Cargando…
Evaluation of a package of risk-based pharmaceutical and lifestyle interventions in patients with hypertension and/or diabetes in rural China: A pragmatic cluster randomised controlled trial
BACKGROUND: Primary prevention of cardiovascular disease (CVD) requires adequate control of hypertension and diabetes. We designed and implemented pharmaceutical and healthy lifestyle interventions for patients with diabetes and/or hypertension in rural primary care, and assessed their effectiveness...
Autores principales: | Wei, Xiaolin, Zhang, Zhitong, Chong, Marc K. C., Hicks, Joseph P., Gong, Weiwei, Zou, Guanyang, Zhong, Jieming, Walley, John D., Upshur, Ross E. G., Yu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284676/ https://www.ncbi.nlm.nih.gov/pubmed/34197452 http://dx.doi.org/10.1371/journal.pmed.1003694 |
Ejemplares similares
-
Implementation of a comprehensive intervention for patients at high risk of cardiovascular disease in rural China: A pragmatic cluster randomized controlled trial
por: Wei, Xiaolin, et al.
Publicado: (2017) -
Protocol for a pragmatic cluster randomised controlled trial for reducing irrational antibiotic prescribing among children with upper respiratory infections in rural China
por: Zou, Guanyang, et al.
Publicado: (2016) -
Use of Medications and Lifestyles of Hypertensive Patients with High Risk of Cardiovascular Disease in Rural China
por: Zou, Guanyang, et al.
Publicado: (2015) -
Process Evaluation of a Clustered Randomized Control Trial of a Comprehensive Intervention to Reduce the Risk of Cardiovascular Events in Primary Health Care in Rural China
por: Zou, Guanyang, et al.
Publicado: (2020) -
Long-term outcomes of an educational intervention to reduce antibiotic prescribing for childhood upper respiratory tract infections in rural China: Follow-up of a cluster-randomised controlled trial
por: Wei, Xiaolin, et al.
Publicado: (2019)